September 24, 2021 | 18:00
Pfizer confirms that there is no safety issue regarding the presence of opaque amorphous particles found in the new coronavirus vaccine in Japanese cities.
September 24, 2021 | 17:21
President Nguyen Xuan Phuc visited Pfizer, one of the world’s leading pharmaceutical and biotechnology corporations, on September 23 (local time).
August 16, 2021 | 10:43
The Vietnamese government on August 14 issued Resolution No.90/NQ-CP approving the purchase of nearly 20 million doses of Pfizer-BioNTech COVID-19 vaccine.
August 03, 2021 | 11:00
While the world’s largest COVID-19 vaccine producers made huge profits in the first half of 2021, sales figures in various countries point to the apparent conclusion that the same groups are profiteering from monopolies on the vaccines.
July 21, 2021 | 09:04
Ho Chi Minh City will distribute AstraZeneca, Pfizer, and Moderna vaccines with more than 1.1 million doses in the fifth round of its vaccination campaign.
July 06, 2021 | 11:16
According to the MoH, more than 90,000 doses of Pfizer/BioNtech's vaccines are expected to arrive at Noi Bai International Airport on the morning of July 7.
June 13, 2021 | 10:00
The MoH signed Decision No.2908/QD-BYT, officially approving Comirnaty – the Covid-19 vaccine of Pfizer/BioNTech for emergency use.
May 05, 2021 | 08:00
While some of the world’s largest vaccine makers have committed to increase COVID-19 vaccine access to middle and low-income countries, there remains uncertainty over patent waivers.
April 26, 2021 | 15:10
Pfizer, Johnson & Johnson, and AstraZeneca have paid enough in dividends and stock buybacks to shareholders to inoculate the population of Africa.
July 16, 2020 | 14:00
International pharma giants like Pfizer, GSK, and Novartis are expected to be strongly hit soon by a price cut under Vietnam’s new tender rules for branded drugs, enabling local patients to receive an increase in pharmaceutical access at affordable prices.
March 12, 2020 | 08:00
Betting on Vietnam’s future growth potential driven by landmark free trade agreements, investors from both the United States and the ASEAN are releasing new plans to venture further into the lucrative local market, with healthcare being a heavy focus.
January 06, 2020 | 12:04
Pfizer, Sanofi, and GlaxoSmithKline are reported to plan increasing drug prices in the US in 2020, triggering public concerns over a similar hike in Vietnam.